[Clinical studies on serum lipids in the patients with tumor of the prostate gland. 3rd report: changes of serum lipid peroxide levels during estrogen therapy for prostatic cancer and therapeutic and preventive effect of riboflavin tetrabutylate for hyperlipidemia].
D000368:Aged; D004967:Estrogens / Q000627:therapeutic use*; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000517:prevention & control; D008054:Lipid Peroxides / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000097:blood* / Q000188:drug therapy; D012256:Riboflavin / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004967:Estrogens; D008054:Lipid Peroxides; C009175:riboflavin tetrabutyrate; D012256:Riboflavin